PathAI and Moffitt Cancer Center announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight Dx, across Moffitt’s pathology programs to transform cancer detection and innovation.
AISight Dx, is PathAI’s cloud-native digital pathology image management system designed to support both laboratory workflow and translational research use cases. It combines enterprise-scale slide management, viewing, and collaboration with seamless AI integration, driving scalable pathology operational efficiencies and enhanced speed and accuracy. The partnership also establishes a framework for joint research programs, collation of real-world multimodal data, initiatives to support clinical trials and biopharma collaborations, and the co-development of next-generation AI-based diagnostics to enhance precision medicine.
